IOSP
Innospec Inc
IOSP at a glance — five pillars scored 0–100 from real filed financials.
Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
Market Cap
$0.00
P/E
—
Forward P/E (est.)
—
ROE
—
Revenue Growth
—
EPS Growth
—
Profit Margin
—
FCF Yield
—
Debt / Equity
—
ROIC
8.0%
Interest Coverage
34.08x
Current Ratio
2.98x
Dividend Yield
—
Implied Growth (rev. DCF)
—
Rating Score
0/100
Innospec Inc (IOSP) is a small-cap company in the Chemicals industry, part of the Materials sector of the S&P 500.
In its latest reported year it generated about $1.78B in revenue.
Our model rates IOSP Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
4Y CAGR
4.6%
Revenue moved from $883.40M in 2016 to $1.78B in 2025, a 8.1% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.
Gross Margin
27.7%
Operating Margin
7.3%
Net Margin
—
ROE
—
Total Debt
$0.00
Net Debt
-$289.10M
Net cash position
Net Debt / EBITDA
-2.23x
Debt / Equity
—
Leverage: debt-to-equity is n/a, and operating profit covers interest about 34.1x, with a current ratio of 3.0x. Detailed balance-sheet leverage is limited for this name. It carries roughly $0.00 of total debt against $289.10M of cash.
Operating CF
$138.30M
Free Cash Flow
$88.00M
FCF Margin
4.9%
In the latest year Innospec Inc produced about $138.30M of operating cash flow and $88.00M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
P/E
—
P/S
—
P/B
—
EV / EBITDA
—
IOSP trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$61.34
Current price
—
Starting FCF (latest 10-K)
$88.00M
Growth, years 1–5
4.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where IOSP sits versus its Materials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 22 Materials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How IOSP stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
In the Materials sector (38 S&P 500 companies), IOSP ranks #33 of 38 by our overall rating.
P/E vs sector
—
median 25.2x
ROE vs sector
—
median 14.1%
Growth vs sector
—
median 4.9%
Sector rank
#33
of 38 by rating
Peers are the closest Materials companies by sub-industry and size. Sector median is across all 38 S&P 500 names in the sector. Educational, not a recommendation.
The case for IOSP:
- As an established S&P 500 member in Materials, it brings scale and a long operating history.
The case against IOSP:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Innospec Inc is a small-cap materials business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
IOSP — frequently asked questions
Is IOSP a good stock to buy?
We don't give buy or sell advice. Review Innospec Inc's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.
Where does IOSP's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Innospec Inc's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for IOSP calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this IOSP analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell IOSP. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.